A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
about
Gene doping: gene delivery for olympic victoryEffects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscleAssembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.The Tetracycline Responsive System.Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment.
P2860
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
@en
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation.
@nl
type
label
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
@en
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation.
@nl
prefLabel
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
@en
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation.
@nl
P2093
P2860
P1476
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation
@en
P2093
Carly Bright
Maria C Subang
Mariana Berenstein
Osvaldo L Podhajcer
Patricia Blanco
Rewas Fatah
Yuti Chernajovsky
P2860
P2888
P304
P356
10.1007/S00109-011-0826-3
P577
2011-10-30T00:00:00Z